152305-23-2,
(S)-4-(4-aminobenzyl)oxazolidin-2-one,
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone,
(S)-4-(4-Aminobenzyl)-2-oxazolidinone,
(S)-4-(4-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE,
340041-89-6,
(S)-4-(4-AMINO-BENZYL)-OXAZOLIDINE-2-ONE,
2-OXAZOLIDINONE, 4-[(4-AMINOPHENYL)METHYL]-, (4S)-,
(S)-4-(4-Aminobenzyl)-1,3-oxozolidin-2-one,
MFCD03411476,
(4S)-4-[(4-aminophenyl)methyl]-1,3-oxazolidin-2-one,
(s)-4-(4-aminobenzyl)-oxazolidine-2-one,
s-4-(4-aminobenzyl)-1,3-oxazolidin-2-one,
(4S)-4-[(4-aminophenyl)methyl]oxazolidin-2-one,
(4S)-4-[(4-Aminophenyl)methyl]-2-oxazolidinone,
J-502456,
2-Oxazolidinone,4-[(4-aminophenyl)methyl]-, (4S)-,
AK-28626,
PubChem7548,
AC1OFFG2,
SCHEMBL825617,
Jsp002933,
CTK4C7393,
WNAVSKJKDPLWBD-VIFPVBQESA-N,
ACN-S003838,
ACT04409,
KS-000009VJ,
ZINC4101055,
AN-915,
ANW-21391,
CA-402,
SBB070336,
AKOS015855677,
AKOS015889599,
AB14099,
FCH4032680,
RP25178,
RTR-006276,
(s)-4-(4-aminobenzyl)-2-oxazolidinon,
AJ-48058,
BR-28626,
CC-01409,
CJ-11321,
DS-11087,
OR350358,
AB0012031,
AX8000136,
ST2414639,
TL8001127,
TR-006276,
(4s)-(4-aminobenzyl)-2-oxazolidine-2-one,
AM20060519,
FT-0643483,
(s)-4-(4-aminobenzyl)-1,3-oxazolidin 2-one,
(S)-4-(4-aminobenzyl)-1l3-oxazolidin-2-one,
(s)-4-(4-aminobenzyl)-2-(1h)-oxazolidinone,
A-3440,
(4S)-4-(4-amino-benzyl)-1,3-oxazolidin-2-one,
305A232,
C-08405,
(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone, 97%,
Zolmitriptan Related Compound G, United States Pharmacopeia (USP) Reference Standard,
Not Available,
C10H12N2O2,
ZINC02524856,
CB11246,
CID7099156,
CS-O-31543,
A2095,
A3348,
(s)-4-(4-aminobenzyl)-1,3-oxazolidine-2-one,
(S)-4-(4'-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE,
(S)-4-(4-Aminobenzyl)-2-oxazolidinone, 98% - 1G 1g,
171550-12-2,